Neuro42

San Francisco, CA · Founded 2020 · Privately Held (backing)

Developer of portable magnetic resonance imaging machines designed to offer diagnosis and interventions for neurological conditions. Neuro42 is based in San Francisco, CA and was founded in 2020. Its last known valuation is $135 million. It has raised $30 million across 2 recorded rounds; the latest was a $15.6 million early-stage round in Sep 2024.

Last price · $/share
—
Implied valuation
$135.0M
Total raised
$30.0M
Last round
Early Stage VC
Sep 2024
How much has Neuro42 raised?
$30.0Macross 2 recorded rounds · May 2024 – Sep 2024

Most recently, Neuro42 raised $15.6M in its Early Stage VC (Sep 2024).

Free account
More of Neuro42 with a free account
  • ·The complete investor list: 12 names
  • ·Watch Neuro42: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Neuro42 round by round

2 rounds
Sep 2024Early Stage VC$15.6MSEC filing▮
85 investors participated
May 2024Early Stage VC$6.7MSEC filing▮
24 investors participated

How much has Neuro42 raised?

Neuro42 has raised $30 million in total; 2 of its rounds are on record. The largest on record was a $6.7 million early-stage round in May 2024; the most recent was a $15.6 million early-stage round in Sep 2024.

Neuro42 has filed 2 Form Ds with the SEC, most recently in Sep 2024 ($15.6 million sold to 85 investors).

Neuro42 investors

12 investors are on record for Neuro42, including Keiretsu Forum, ShangBay Capital, Blacktop Capital and Frederic Moll. The early-stage round in Sep 2024 drew 85 investors.

For fundraisers
Raising for a company like Neuro42?

12 investors have backed Neuro42.

See all 12 investors →

Frequently asked about Neuro42

How much has Neuro42 raised?
Neuro42 has raised $30.0M in total across 2 recorded funding rounds.
When was Neuro42's last funding round?
Neuro42's most recent recorded round was Early Stage VC in Sep 2024, raising $15.6M.